Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: BRADLEY PHARMACEUTICALS INC
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 02066971 | BRADLEY PHARMACEUTICALS INC | NEOLOID EML 36.4% | Human | No | OTC | 1 | CASTOR OIL | 36.4 % |
Cancelled Post Market | 02050285 | BRADLEY PHARMACEUTICALS INC | TRANS-PLANTAR 20MM PLS 15% | Human | No | OTC | 1 | SALICYLIC ACID | 15 % |
Cancelled Post Market | 02050293 | BRADLEY PHARMACEUTICALS INC | TRANS-VER-SAL 6MM PLS 15% | Human | No | OTC | 1 | SALICYLIC ACID | 15 % |
Application information
Related information
Contact us
Version 4.0.3